# FDA recall D1834-2015

> **Apotex Inc.** · Class III · drug recall initiated 2015-07-21.

## Product

Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bottles, Rx Only, Apotex Corp. Manufactured by Apotex Research Private Limited, Bangalore, Karnataka 560 099, India; Manufactured for: Apotex Corp., Weston, FL 33326. NDC 60505-2742-5.

## Reason for recall

Failed Dissolution Specification: One lot of product did not meet the first stage dissolution specification limits.

## Distribution

Nationwide and Puerto Rico

## Key facts

- **Recall number:** D1834-2015
- **Recalling firm:** Apotex Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2015-07-21
- **Report date:** 2015-10-07
- **Termination date:** 2017-02-15

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Toronto, Ontario, Canada

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D1834-2015

## Citation

> AI Analytics. FDA recall D1834-2015. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D1834-2015. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*